Hot Biotech Stocks To Buy Right Now: Foundation Medicine Inc (FMI)
Foundation Medicine, Inc., incorporated on November 12, 2009, is a commercial-stage company. The Company is focused on fundamentally changing the way patients with cancer are treated. The Companys platform includes methods and algorithms for analyzing tumor tissue samples across all types of cancer, as well as information aggregation and concise reporting capabilities. Its products provide genomic information about each patients individual cancer, enabling physicians to optimize treatments in clinical practice and enabling biopharmaceutical companies to develop targeted oncology therapies more effectively.
FoundationOne, its first clinical product, is, to its knowledge, the only commercially available comprehensive molecular information product designed for use in the routine care of patients with cancer. In addition, the Company is considered a non-contracting provider by commercial third-party payors because it has not entered into specific contracts to provide FoundationOne to their covered patients, and as a result it takes on primary responsibility for obtaining reimbursement on behalf of patients.
Advisors' Opinion:- [By Bryan Murphy]
Eat your heart out Foundation Medicine Inc. (NASDAQ:FMI). And WebMD Health Corp. (NASDAQ:WBMD)? Don't even bother trying. CollabRx Inc. (NASDAQ:CLRX) has built a better mousetrap, and if yesterday's announcement is a sign of things to come, CLRX could prove to be a very compelling investment.
- [By John Udovich]
Yesterday, small cap biotech Acceleron Pharma Inc (NASDAQ: XLRN) rose 9.76%plus shares are up 183.6% for retail investors since its September IPO, meaning its worth taking a closer look at the stock along with the performance of other biotech IPOs like BIND Therapeutics Inc (NASDAQ: BIND), Ophthotech Corp (NASDAQ: OPHT) and Foundation Medicine Inc (NASDAQ: FMI) which also debuted at the same time.
- [By Dan Caplinger]
In the following video, Dan Caplinger, director of investment planning for The Motley Fool, looks at whether the IPO market is overheating once more. Dan points to some huge gains from recent IPOs, with FireEye (NASDAQ: FEYE ) rising 80% in its first day while Rocket Fuel (NASDAQ: FUEL ) and Foundation Medicine (NASDAQ: FMI ) both posted gains of between 90% and 100%. Dan also highlights Sprouts Farmers Market (NASDAQ: SFM ) , which climbed a whopping 123% in its first day as a public company.
source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/hot-biotech-stocks-to-buy-right-now.html
No comments:
Post a Comment